Current Drug Metabolism


Michael Sinz

Bristol Myers Squibb

Princeton, NJ




Become EABM
Become Reviewer

Drug Interactions between Nine Antifungal Agents and Drugs Metabolized by Human Cytochromes P450

Volume:15   Issue: 7
Pp: 651-679
Toshiro Niwa, Yurie Imagawa and Hiroshi Yamazaki
DOI: 10.2174/1389200215666141125121511

Role of Membrane Transporters and Metabolizing Enzymes in Ocular Drug Delivery

Volume:15   Issue: 7
Pp: 680-693
Ramya Krishna Vadlapatla, Aswani Dutt Vadlapudi, Dhananjay Pal and Ashim K. Mitra
DOI: 10.2174/1389200215666140926152459

Safety and Tolerability of Agomelatine: Focus on Hepatotoxicity

Volume:15   Issue: 7
Pp: 694-702
Maximilian Gahr, Wolfgang Kratzer, Michael Fuchs and Bernhard J. Connemann
DOI: 10.2174/1389200215666140926155041

Resveratrol-Mediated Reversal of Tumor Multi-Drug Resistance

Volume:15   Issue: 7
Pp: 703-710
Yutong Hu, Chuangang Li, Hong Li, Molin Li and Xiaohong Shu
DOI: 10.2174/1389200215666140926153522

Pharmacogenetic Prediction of Individual Variability in Drug Response Based on CYP2D6, CYP2C9 and CYP2C19 Genetic Polymorphisms

Volume:15   Issue: 7
Pp: 711-718
Shafqat Rasul Chaudhry, Sajjad Muhammad, Moritz Eidens, Marco Klemm, Dilaware Khan, Thomas Efferth and Maria-Paz Weisshaar
DOI: 10.2174/1389200215666141125121952

Protein Engineering: A New Frontier for Biological Therapeutics

Volume:15   Issue: 7
Pp: 743-756
Peter H. Tobin, David H. Richards, Randolph A. Callender and Corey J. Wilson
DOI: 10.2174/1389200216666141208151524

Erratum: promotion: free to download

Volume:15   Issue: 7
Pp: 757-758

DOI: 10.2174/138920021507150126222542